Biohaven Ltd.
BHVN
$38.97
$0.431.12%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 28.02% | -48.98% | 55.56% | 27.35% | -287.59% |
| Total Depreciation and Amortization | 450.58% | 307.96% | 341.20% | 559.60% | -49.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.96% | -79.75% | -97.60% | -95.15% | 997.78% |
| Change in Net Operating Assets | -772.57% | 106.31% | 104.98% | -192.03% | -115.06% |
| Cash from Operations | -52.35% | 0.78% | 34.61% | -31.96% | -128.12% |
| Capital Expenditure | -56.67% | 72.41% | 40.74% | -198.78% | -49.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.69% | -- | -- | -- | -- |
| Cash from Investing | 98.52% | 1,394.19% | 311.79% | -330.49% | -131,251.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -12.78% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -101.09% | -131.09% | -123.42% | 15.78% | 197.44% |
| Cash from Financing | -53.74% | -131.09% | -123.42% | 15.78% | 310.07% |
| Foreign Exchange rate Adjustments | -172.26% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.03% | -376.63% | 166.63% | -44.29% | 166.93% |
